PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
PetMeds appointed Tamar Elkeles, PhD as an independent director and Chair of the Compensation and Human Capital Committee, effective September 17, 2026.
Dr. Elkeles spent 23 years at Qualcomm as Chief Learning & Talent Officer, helping scale the company from $100 million to over $25 billion in revenue.
The appointment follows a previously announced leadership transition that installed Jeff Willard as CEO and Justin Mennen as incoming Board Chair, part of an ongoing board refreshment effort.